A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma

Anna Nowak, Michael Millward, Jenette Creaney, Roslyn Francis, Ian Dick, Arman Hasani, A. Van Der Schaaf, A. Segal, Arthur Musk, Michael Byrne

Research output: Contribution to journalArticlepeer-review

70 Citations (Scopus)
Original languageEnglish
Pages (from-to)1449-1456
JournalJournal of Thoracic Oncology
Issue number9
Publication statusPublished - 2012

Cite this